Next, we analyzed MEK signature via nanostring assay in FFPET (Formalin fixed paraffin embedded tissue) samples from advanced GC patients and then performed a correlative analysis with MEK signature status and KRAS genotype in GC. The gene discussed is KRAS; the disease is gastric cancer.